510(k) Report

510(k) · Cleared

Recalled · 2010

Access Progesterone Assay

K955769510(k) TraditionalCleared Feb 5, 199646-day reviewClass I21 CFR 862.1620Recalls 2

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Bio-Rad Laboratories, Inc. · JLS Radioimmunoassay, Progesterone

Cleared on Feb 5, 1996 after a 46-day review. FDA has not posted a summary or statement for it, so its predicates are not known. It has been recalled 2 times.

Decided
Feb 5, 1996
Review
46 days
Class
Class I
Product code
JLS
Recalls
2
Predicates
0

FDA has not posted a summary or statement for it, so its predicates are not known.

FIG. 1 — Lineage of K955769Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JLS? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against?

FDA has not posted a summary or statement for it, so its predicates are not known.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Feb 17, 2010Not classifiedZ-2620-2010OtherThe recall was initiated by Beckman Coulter after the firm confirmed customer reports that the affected lot of Access Cortisol reagent (REF 33600) identified above may produce suppressed patient results. Beckman Coulter also confirmed…
Dec 6, 2002Not classifiedZ-0494-03OtherPrimary tube sampling issue may cause false low results.

No ancestor or descendant has a Class I recall.

How does its category compare?

All JLS devices

JLS Radioimmunoassay, Progesterone: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · JLS

FDA has decided no JLS device since 2007.

Median 510(k) review, days · JLS

Too few JLS 510(k)s in any year since 2007 to give a median.

Recalls per year · JLS

1in 2022

2008: 12010: 12018: 32021: 12022: 1
2007high 3 (2018) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JLS

3in 2025

2010: 12011: 12012: 62013: 192014: 12015: 12016: 62017: 92018: 12019: 72020: 42021: 412022: 172023: 182024: 72025: 3
2007high 41 (2021) · low 0 (2007)2025

MAUDE reports naming product code JLS, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—10
20090—00
20100—11
20110—01
20120—06
20130—019
20140—01
20150—01
20160—06
20170—09
20180—31
20190—07
20200—04
20210—141
20220—117
20230—018
20240—07
20250—03
20260—0—
Cite this page

510(k) Report. “K955769: Access Progesterone Assay.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K955769

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026